CA2304451A1 - Specific immunophilin ligands useful as anti-asthmatic, anti-allergic, anti-rheumatic, immunosuppressive, antipsoriatic and neuroprotective agents - Google Patents

Specific immunophilin ligands useful as anti-asthmatic, anti-allergic, anti-rheumatic, immunosuppressive, antipsoriatic and neuroprotective agents Download PDF

Info

Publication number
CA2304451A1
CA2304451A1 CA002304451A CA2304451A CA2304451A1 CA 2304451 A1 CA2304451 A1 CA 2304451A1 CA 002304451 A CA002304451 A CA 002304451A CA 2304451 A CA2304451 A CA 2304451A CA 2304451 A1 CA2304451 A1 CA 2304451A1
Authority
CA
Canada
Prior art keywords
groups
carbonyl
indoline
indolin
carbamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002304451A
Other languages
English (en)
French (fr)
Inventor
Dietmar Reichert
Bernhard Kutscher
Stefan Szelenyi
Hildegard Poppe
Gerhard Quinkert
Kay Brune
Holger Bang
Holger Deppe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asta Medica GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2304451A1 publication Critical patent/CA2304451A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA002304451A 1997-09-25 1998-08-20 Specific immunophilin ligands useful as anti-asthmatic, anti-allergic, anti-rheumatic, immunosuppressive, antipsoriatic and neuroprotective agents Abandoned CA2304451A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19742263A DE19742263A1 (de) 1997-09-25 1997-09-25 Neue spezifische Immunophilin-Liganden als Antiasthmatika, Antiallergika, Antirheumatika, Immunsuppressiva, Antipsoriatika, Neuroprotektiva
DE19742263.2 1997-09-25
PCT/EP1998/005300 WO1999015501A1 (de) 1997-09-25 1998-08-20 Spezifische immunophilin-liganden als antiasthmatika, antiallergika, antirheumatika, immunsuppressiva, antipsoriatika, neuroprotektiva

Publications (1)

Publication Number Publication Date
CA2304451A1 true CA2304451A1 (en) 1999-04-01

Family

ID=7843549

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002304451A Abandoned CA2304451A1 (en) 1997-09-25 1998-08-20 Specific immunophilin ligands useful as anti-asthmatic, anti-allergic, anti-rheumatic, immunosuppressive, antipsoriatic and neuroprotective agents

Country Status (12)

Country Link
EP (1) EP1017673A1 (no)
JP (1) JP2001517653A (no)
KR (1) KR20010040253A (no)
AU (1) AU9345098A (no)
BR (1) BR9813226A (no)
CA (1) CA2304451A1 (no)
DE (1) DE19742263A1 (no)
HU (1) HUP0004294A3 (no)
IL (1) IL133246A0 (no)
NO (1) NO20001510L (no)
WO (1) WO1999015501A1 (no)
ZA (1) ZA987819B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002516904A (ja) 1998-06-03 2002-06-11 ジーピーアイ ニル ホールディングス インコーポレイテッド Ｎ−複素環式カルボン酸またはカルボン酸等配電子体のｎ−結合スルホンアミド
US6300341B1 (en) 1998-09-30 2001-10-09 The Procter & Gamble Co. 2-substituted heterocyclic sulfonamides
US6417189B1 (en) 1999-11-12 2002-07-09 Gpi Nil Holdings, Inc. AZA compounds, pharmaceutical compositions and methods of use
US7253169B2 (en) 1999-11-12 2007-08-07 Gliamed, Inc. Aza compounds, pharmaceutical compositions and methods of use
ATE319712T1 (de) 1999-12-21 2006-03-15 Mgi Gp Inc Hydantoin derivate, pharmazeutische zusammensetzungen und verfahren zu ihrer verwendung
CA2570531A1 (en) * 2004-06-18 2005-12-29 Kristofer Olofsson Indoles useful in the treatment of inflammation
AU2005254782A1 (en) 2004-06-18 2005-12-29 Biolipox Ab Indoles useful in the treatment of inflammation
CA2571710A1 (en) 2004-06-24 2006-11-02 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
BRPI0519774A2 (pt) 2005-01-19 2009-02-10 Biolipox Ab composto ou um sal farmaceuticamente aceitÁvel do mesmo, formulaÇço farmacÊutica, uso de um composto ou um sal farmaceuticamente aceitÁvel do mesmo, mÉtodo de tratamento de uma doenÇa em que inibiÇço da atividade de um membro da famÍlia mapeg É desejada e/ou necessÁria, produto combinado, e, processo para a preparaÇço de um composto
WO2013138600A1 (en) * 2012-03-16 2013-09-19 Rosen Eliot M Radioprotector compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192773A (en) * 1990-07-02 1993-03-09 Vertex Pharmaceuticals, Inc. Immunosuppressive compounds
MX9202466A (es) * 1991-05-24 1994-06-30 Vertex Pharma Compuestos inmunosupresores novedosos.
US5385918A (en) * 1993-02-09 1995-01-31 Miles Inc. Aminomethylene-peptides as immunosuppressants
US5859031A (en) * 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US5614547A (en) * 1995-06-07 1997-03-25 Guilford Pharmaceuticals Inc. Small molecule inhibitors of rotamase enzyme
US5795890A (en) * 1995-09-27 1998-08-18 Ono Pharmaceutical Co., Ltd. Sulfonamide derivatives
DE19542189A1 (de) * 1995-11-13 1997-05-15 Hoechst Ag Cyclische N-substituierte alpha-Iminohydroxamsäuren
DE19616509A1 (de) * 1996-04-25 1998-01-15 Asta Medica Ag Neue spezifische Immunophilin-Liganden als Antiasthmatika, Immunsuppressiva

Also Published As

Publication number Publication date
NO20001510L (no) 2000-05-22
WO1999015501A1 (de) 1999-04-01
NO20001510D0 (no) 2000-03-23
BR9813226A (pt) 2000-08-29
ZA987819B (en) 1999-04-07
EP1017673A1 (de) 2000-07-12
IL133246A0 (en) 2001-04-30
AU9345098A (en) 1999-04-12
HUP0004294A2 (hu) 2001-05-28
KR20010040253A (ko) 2001-05-15
JP2001517653A (ja) 2001-10-09
HUP0004294A3 (en) 2001-11-28
DE19742263A1 (de) 1999-04-01

Similar Documents

Publication Publication Date Title
RU2237661C2 (ru) N-замещенные индол-3-глиоксиламиды и лекарственный препарат, обладающие противоастматическим, противоаллергическим и иммунодепрессивным/иммуномодуляторным действием, способ получения соединений(варианты) и способ получения лекарственного препарата
US6251932B1 (en) Immunophilin ligands
US6150527A (en) Synthetic multimerizing agents
US5710129A (en) Inhibitors of SH2-mediated processes
US7781477B2 (en) Therapeutic use of N-(1H-Indolyl)-1H-indole-2-carboxamide derivatives
NO861141L (no) Fremgangsmaate ved fremstilling av therapeutisk virksomme n,n[-dialkylguanidino-dipeptider.
JP6742343B2 (ja) ２環性複素環化合物
CA2304451A1 (en) Specific immunophilin ligands useful as anti-asthmatic, anti-allergic, anti-rheumatic, immunosuppressive, antipsoriatic and neuroprotective agents
US5703106A (en) Antagonists of endothelin receptors
KR20020063245A (ko) 항종양 효과를 갖는 치환된 ｎ-벤질-인돌-3-일 글리옥실산유도체
PT92554A (pt) Processo para a preparacao de peptideos inibidores de protease retroviral
EP0737678B1 (en) 4-Indolylpiperazinyl derivatives
AP424A (en) Piperidine derivatives, their preparation and their application in therapy.
CA2136836C (en) Piperidinyl-terminated n-(dihydroxy alkyl)-ethynyl-alanine amides for treatment of hypertension
CA2486933A1 (en) Tetrahydropyran derivative
EP0741697A1 (en) Amino acid derivatives and their use as phospholipase a2 inhibitors
CN116283918A (zh) 一种降解受体酪氨酸激酶的双功能化合物及其应用
JP3102895B2 (ja) 抗喘息薬、免疫抑制薬としての特異的なイムノフィリン―リガンド
MXPA99012020A (en) Specific immunophilin ligands useful as anti-asthmatic, anti-allergic, anti-rheumatic, immunosuppressive, antipsoriatic and neuroprotective agents
NZ228825A (en) Esters of aminoacyl cyclic amino acid derivatives and pharmaceutical compositions
RU2172743C2 (ru) Иммунофилин-специфические лиганды в качестве антиастматических и иммунодепрессантных агентов и способ их получения, фармацевтически готовая форма, лекарственное средство и способ его получения
JP2820881B2 (ja) エリプティシン誘導体およびその製法
MXPA98008546A (en) Specific binders of immunophylin as antimatic, immunosupreso
WO2023055580A9 (en) Benzylthiophene derivatives
WO1997011960A1 (en) Antagonists of endothelin receptors

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued